跳至主要内容
临床试验/NCT04840953
NCT04840953已完成不适用

Negative Pressure Therapy, Minimally Invasive and Accessible Technique in the Treatment of Massive Subcutaneous Emphysema in COVID-19 or Non Infected Critical Patients

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana1 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2020年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
2
试验地点
1
主要终点
Resolution time of emphysema with negative pressure therapy

研究概览

简要总结

Background Numerous surgicals treatments have been described for the massive subcutaneous emphysema; however, some of these techniques cannot be carried out in a critical care unit and they are related with high morbidity and exposure in positive SARS COV-2 patients. More effective, less invasive and isolated procedures should be implemented.

Technique Negative pressure therapy (NPT) that can allow effective solving of massive subcutaneous emphysema in a short period (5 days) with a minimally invasive approach at the bedside in Covid-19 or non infected critical patients.

Conclusion NPT is an effective and low invasive strategy for the management of EES in critical patients with high risk of mortality.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Subcutaneous emphysema that compromises ventilation

排除标准

  • Declined Therapy

结局指标

主要结局

Resolution time of emphysema with negative pressure therapy

时间窗: Days

Days

次要结局

未报告次要终点

研究者

发起方
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
申办方类型
Other
责任方
Principal Investigator
主要研究者

Luis Sánchez Guillen

Colorrectal Surgeon

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

研究点 (1)

Loading locations...

相似试验